Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events.

Circ Cardiovasc Genet 2010 Apr 19;3(2):207-14. Epub 2010 Feb 19.

Department of Medicine, Duke University, Durham, NC, USA.

Background: Molecular tools may provide insight into cardiovascular risk. We assessed whether metabolites discriminate coronary artery disease (CAD) and predict risk of cardiovascular events.

Methods And Results: We performed mass-spectrometry-based profiling of 69 metabolites in subjects from the CATHGEN biorepository. To evaluate discriminative capabilities of metabolites for CAD, 2 groups were profiled: 174 CAD cases and 174 sex/race-matched controls ("initial"), and 140 CAD cases and 140 controls ("replication"). To evaluate the capability of metabolites to predict cardiovascular events, cases were combined ("event" group); of these, 74 experienced death/myocardial infarction during follow-up. A third independent group was profiled ("event-replication" group; n=63 cases with cardiovascular events, 66 controls). Analysis included principal-components analysis, linear regression, and Cox proportional hazards. Two principal components analysis-derived factors were associated with CAD: 1 comprising branched-chain amino acid metabolites (factor 4, initial P=0.002, replication P=0.01), and 1 comprising urea cycle metabolites (factor 9, initial P=0.0004, replication P=0.01). In multivariable regression, these factors were independently associated with CAD in initial (factor 4, odds ratio [OR], 1.36; 95% CI, 1.06 to 1.74; P=0.02; factor 9, OR, 0.67; 95% CI, 0.52 to 0.87; P=0.003) and replication (factor 4, OR, 1.43; 95% CI, 1.07 to 1.91; P=0.02; factor 9, OR, 0.66; 95% CI, 0.48 to 0.91; P=0.01) groups. A factor composed of dicarboxylacylcarnitines predicted death/myocardial infarction (event group hazard ratio 2.17; 95% CI, 1.23 to 3.84; P=0.007) and was associated with cardiovascular events in the event-replication group (OR, 1.52; 95% CI, 1.08 to 2.14; P=0.01).

Conclusions: Metabolite profiles are associated with CAD and subsequent cardiovascular events.

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCGENETICS.109.852
Publisher Site
http://dx.doi.org/10.1161/CIRCGENETICS.109.852814DOI Listing
April 2010
104 Reads

Publication Analysis

Top Keywords

cardiovascular events
20
associated cad
12
artery disease
8
replication p=001
8
death/myocardial infarction
8
subsequent cardiovascular
8
metabolites factor
8
cad cases
8
factor initial
8
coronary artery
8
p=002 factor
8
factor
7
cardiovascular
7
cad
7
95%
6
metabolites
6
group
5
events
5
group n=63
4
"event-replication" group
4

References

(Supplied by CrossRef)

PLoS Genet 2009

Circulation 1991

Clin Chem 1995

Similar Publications